Logo-jcvtr

J Cardiovasc Thorac Res. 2020;12(2): 140-144. doi: 10.34172/jcvtr.2020.23
PMID: 32626555        PMCID: PMC7320999

Short Communication

Comparison of apolipoprotein-A1 levels between paroxysmal atrial fibrillation patients and healthy subjects

Tufan Çınar 1 * ORCID, Veysel Ozan Tanık 2, Kadir Gürkan 3

Cited by CrossRef: 5

1- Ghaemi F, Rabizadeh S, Yadegar A, Mohammadi F, Asadigandomani H, Bafrani M, Reyhan S, Esteghamati A, Nakhjavani M. ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study. BMC Cardiovasc Disord. 2024;24(1) [Crossref]
2- Zhong X, Yu J, Zhao D, Teng J, Jiao H. Association between serum apolipoprotein A1 and atrial fibrillation in the Chinese population: a case–control study. BMC Cardiovasc Disord. 2023;23(1) [Crossref]
3- Štolbová K, Novodvorský P, Jakubíková I, Dvořáková I, Mráz M, Wichterle D, Kautzner J, Haluzík M. Effect of Complex Weight-Reducing Interventions on Rhythm Control in Obese Individuals with Atrial Fibrillation Following Catheter Ablation: A Study Protocol. Adv Ther. 2021;38(4):2007 [Crossref]
4- Li B, Ze F, Mi L, Chen X, Niu X, Hu S, Zhao N. Chief Editor Internatioal Journal of Cardiologyassessing Causality between Human Plasma Proteins and Atrial Fibrillation: A Two-Sample Mendelian Randomization Study. SSRN Journal. 2022; [Crossref]
5- Yuan H, Jiao H, Liu X, Hao H, Liu Y, Xue Y, Li Y. Association of Serum Uric Acid with Non-Valvular Atrial Fibrillation: A Retrospective Study in China. IJGM. 2024;Volume 17:1533 [Crossref]
6- Zhong X, Jiao H, Zhao D, Teng J. A case–control study to investigate association between serum uric acid levels and paroxysmal atrial fibrillation. Sci Rep. 2022;12(1) [Crossref]
7- Tajik B, Tuomainen T, Jarroch R, Kauhanen J, Lip G, Isanejad M. Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD). Journal of Clinical Lipidology. 2022;16(4):447 [Crossref]